Displaying 179 (all) recruiting clinical trials.
-
A Phase 1 Study with an Expansion Cohort/Randomized Phase II Study of the Combination of Ipilimumab Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma
If you have been newly diagnosed with relapsed/refractory Hodgkin lymphoma and are exploring treatment options, you may qualify for a clinical trial studying effect ...
Phase
Interventional
-
Phase 2 Study Of Cabozantinib (XL184) For Plexiform Neurofibromas In Subjects With Neurofibromatosis Type 1 Age 16 Years Or Greater
If you have been diagnosed with Neurofibromatos Type 1 (NF-1), a condition affecting the nervous system, and plexiform neurofibroma (a type of rare, noncancerous tumor ...
Phase
Interventional
-
NSABP B51: Phase 3 Trial Evaluating Post-Mastectomy Chestwall And Post-Lumpectomy Regional Nodal Irradiation In Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy who Convert To Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
If you have been diagnosed with breast cancer and have been treated with chemotherapy followed by breast surgery called a lumpectomy (surgical removal of tumor ...
Phase
Interventional
-
Prone Partial Breast Irradiation (PBI): A Prospective Randomized Trial Comparing Five Versus Three Fractions
If you have been diagnosed with Stage 0 or I breast cancer, also known as ductal carcinoma in situ (DCIS) or T1 breast cancer, you ...
Phase
Interventional
-
Randomized Phase 2 Trial Of Brentuximab Vedotin Or Crizotinib (Commercially Labeled) In Combination With Chemotherapy For Newly Diagnosed Patients With Anaplastic Large Cell Lymphoma (ALCL)
If your child has been newly diagnosed with Anaplastic Large Cell Lymphoma (ALCL), they may qualify to participate in a clinical trial evaluating the addition ...
Phase
Interventional
-
A Phase II Trial of MK3475 in Combination With Gemcitabine and Concurrent Hypofractionated Radiation Therapy as Bladder Sparing Treatment for Muscle-Invasive Urothelial Cancer of the Bladder
The goal of this phase II trial is to assess the efficacy of pembrolizumab added to concurrent radiation and gemcitabine as bladder-preserving treatment for patients ...
Phase
Interventional
-
A Phase II Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Subjects with High Risk Non-muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy
In this study, participants with high risk non-muscle-invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette Guerin (BCG) therapy and who are considered ineligible for or ...
Phase
Interventional
-
Phase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast Cancer
The goal of this Phase II study is to evaluate the safety/tolerability and clinical activity of the combination of nab-paclitaxel and the antibody against ...Phase
Interventional
-
Randomized Phase II And Phase III Studies Of Individualized Treatment For Nasopharyngeal Carcinoma Based On Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
There are two study questions we are asking in this randomized phase II/III trial based on a blood biomarker, Epstein Barr virus (EBV) deoxyribonucleic ...
Phase
Interventional
-
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma Response and Biology-Based Risk factor-guided therapy in treating younger patients with non-high Neuroblastoma
This phase III trial studies how well response and biology-based risk factor-guided therapy works in treating younger patients with non-high risk neuroblastoma. Sometimes a tumor ...
Phase
Interventional
